BMY

Bristol-Myers Squibb
D

BMY

Arincen68/100B

Bristol-Myers Squibb stock buybacks 1989–2026

Bristol-Myers Squibb spent 0.00 USD buying back its shares in Q3 FY2026, the three months to 30 September 2026, with no change to compare on the same quarter a year before. Bristol-Myers Squibb spent 0.00 USD buying back its shares in fiscal year 2025, with no change to compare on the year before.

Last updated 12 Nov 2026 · Next report 4 Feb 2027

Stock buybacks

Growth

Fiscal yearPeriod endingStock buybacksGrowthDividends paidFree cash flow
TTM30 Sept 2026——5.12B9.29B
FY202531 Dec 20250.00—5.05B12.85B
FY202431 Dec 20240.00-100.00%4.86B13.94B
FY202331 Dec 20235.16B-35.57%4.74B12.65B
FY202231 Dec 20228.00B+27.26%4.63B11.95B
FY202131 Dec 20216.29B+306.66%4.40B15.23B
FY202031 Dec 20201.55B-78.82%4.08B13.30B
FY201931 Dec 20197.30B+2,181.25%2.68B7.37B
FY201831 Dec 2018320.00M-87.04%2.61B6.12B
FY201731 Dec 20172.47B+968.83%2.58B4.22B
FY201631 Dec 2016231.00M—2.55B1.84B
FY201531 Dec 20150.00—2.48B1.29B
FY201431 Dec 20140.00-100.00%2.40B2.62B
FY201331 Dec 2013433.00M-81.98%2.31B3.01B
FY201231 Dec 20122.40B+96.81%2.29B6.39B
FY201131 Dec 20111.22B+111.98%2.25B4.47B
FY201031 Dec 2010576.00M—2.20B4.07B
FY200931 Dec 20090.00—2.48B3.34B
FY200831 Dec 20080.00—2.46B2.77B
FY200731 Dec 20070.00—2.21B2.31B
FY200631 Dec 20060.00—2.20B1.29B
FY200531 Dec 20050.00—2.19B1.07B
FY200431 Dec 20040.00—2.17B2.37B
FY200331 Dec 20030.00-100.00%2.17B2.52B
FY200231 Dec 2002164.00M-89.68%2.17B-237.00M
FY200131 Dec 20011.59B-32.04%2.14B4.38B
FY200031 Dec 20002.34B+64.76%1.93B4.06B
FY199931 Dec 19991.42B-9.10%1.71B3.52B
FY199831 Dec 19981.56B+34.34%1.55B2.99B
FY199731 Dec 19971.16B+36.38%1.52B1.71B
FY199631 Dec 1996852.00M+249.18%1.51B2.04B
FY199531 Dec 1995244.00M-65.19%1.50B1.99B
FY199431 Dec 1994701.00M+67.30%1.49B1.73B
FY199331 Dec 1993419.00M+83.77%1.49B2.01B
FY199231 Dec 1992228.00M-48.99%1.43B1.38B
FY199131 Dec 1991447.00M-20.46%1.25B1.21B
FY199031 Dec 1990562.00M+1,001.96%1.12B1.24B
FY198931 Dec 198951.00M—722.00M635.00M

Figures in USD. Free cash flow is operating cash flow less capital expenditure; owner earnings take off only the spending that keeps the business as it is, not the spending to grow it (an estimate by Financial Modeling Prep). Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

The money spent buying back the company's own shares in each period, from the cash flow statement.

See also:Revenue,Net income,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Cash flow

Common questions about Bristol-Myers Squibb's buybacks

Source: Financial Modeling PrepVerified against SEC filings